Achieve Life Sciences (ACHV) Cash from Investing Activities Growth (3y) (2013 - 2020)
Achieve Life Sciences (ACHV) Cash from Investing Activities Growth (3y) (2013 - 2020) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
116.52% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
- |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
38.24% |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
- |
| 10 |
Achieve Life Sciences |
93.71 Mn |
63.22 Mn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2020 |
-26.02% |
| Jun 30, 2020 |
-26.32% |
| Mar 31, 2020 |
-26.00% |
| Dec 31, 2019 |
-25.99% |
| Jun 30, 2019 |
47.15% |
| Mar 31, 2019 |
34.37% |
| Dec 31, 2018 |
-50.91% |
| Sep 30, 2018 |
50.28% |
| Jun 30, 2018 |
-26.26% |
| Mar 31, 2018 |
-86.29% |
| Dec 31, 2017 |
26.40% |
| Sep 30, 2017 |
34.31% |
| Jun 30, 2017 |
-55.90% |
| Mar 31, 2017 |
-15.51% |
| Dec 31, 2016 |
4.30% |
| Sep 30, 2016 |
24.39% |
| Jun 30, 2016 |
-31.23% |
| Mar 31, 2016 |
-36.83% |
| Dec 31, 2015 |
-45.82% |
| Sep 30, 2015 |
-46.16% |
